Bupropion HCl SR 150mg Tablets from Japan
Sustained-release bupropion hydrochloride 150mg tablets for smoking cessation and depression via CNS norepinephrine/dopamine reuptake inhibition. HTS 3004.90.92.49 applies to these other CNS therapeutic medicaments in measured retail doses, distinct from nicotine cessation products in 2404.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Document non-nicotine basis to distinguish from heading 2404 exclusions
• Test for controlled substance scheduling; bupropion analogs may trigger DEA review
• Use temperature-controlled shipping for stability in SR formulations